Real World Evidence: A Data-Centric Approach to Efficiently and Securely Drive Value for the Future of Pharma, New Webinar Hosted by Xtalks

Presenters discuss how clinical innovators, Market Access, IT and HEOR can accelerate RWE initiatives and the implications for data security and healthcare decision-making

Xtalks Life Science Webinars

Join the live broadcast of Xtalks' newest webinar, "Real World Evidence: A Data-Centric Approach to Efficiently and Securely Drive Value for the Future of Pharma," on Tuesday, March 20, 2018, at 11 a.m. EDT (3 p.m. GMT) as real world evidence (RWE) and market access expert Anita Burrell and Bill Fox, Global CTO Healthcare, Life Sciences and Insurance at MarkLogic, will discuss why a data-centric approach to RWE is critical to efficiently driving outcomes and protecting patient PHI.

In this free webinar, participants will gain insights into:

  • Accelerating the development of real world evidence
     
  • Integrating real world data from disparate sources, efficiently and securely
     
  • Using RWE to go from cohort level proof to individual outcomes
     
  • Building predictive simulations and improving protocol design

Janet Woodcock, director of FDA’s Center for Drug Evaluation and Research, recently stated that “the clinical trials system is broken.” Couple that with the rise in RWE initiatives by regulatory agencies — including the 21st Century Cures Act and the IMI GetReal project — and it’s clear that the need to effectively leverage RWE to prove the value and validity of treatments will continue to take on greater urgency for organizations across the healthcare ecosystem.

Data is the Lifeblood of Your Efforts

From electronic health records (EHRs) to wearable devices, the ability to rapidly and securely integrate every type of real world data (RWD) for analysis is key to reducing the time required to develop RWE. Unfortunately, RWD itself presents a formidable hurdle to insight because it is multi-structured, unstructured and stored in disconnected silos or systems (e.g., claims data, registries, patient health surveys, etc.), making search and discovery efforts an acutely painful challenge.

The success of RWE development efforts will be driven by your organization’s ability to efficiently integrate, harmonize and analyze disparate data sets. An agile, secure technology platform is critical to deriving more value from your RWD at less time and cost. 

For more information about this complimentary webinar, visit Real World Evidence: A Data-Centric Approach for Efficiently and Securely Driving Value for the Future of Pharma.

 

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical and biotech companies, private and academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com.

For information about hosting a webinar, visit http://xtalks.com/sponsorship.ashx.

Contact:

Nima Rajan
Tel: +1 (416) 977-6555 ext 352
Email: nrajan@xtalks.com

Source: Xtalks

Share:


Categories: Compliance and Regulations, Pharmaceuticals and Biotech, Healthcare and Medical Informatics, Healthcare Technology, Medical Research

Tags: clinical data, clinical trials, Health Economics & Outcomes Research (HEOR), market access, MarkLogic, pharmacovigilance, Real World Evidence (RWE), Xtalks


Additional Images

Additional Links

About Xtalks

View Website

Xtalks is a leading provider of educational webinars to the global life science, food and medical device community.